Company / Return on Assets (ROA)
CUMBERLAND PHARMACEUTICALS INC Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
1.6%
FY2025
5-year range
-8.3% / 1.6%
FY2021-FY2025
Trend
+119.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) returned to growth in FY2025 after 2 years of decline, reaching 1.6%.
Based on SEC 10-K filings.
1.6% in FY2025 with a 5-year CAGR of +5.1%.
Improved from -6.8% to 1.6% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +5.4pp
- 5-Year Change
- +5.1pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 119.7% year-over-year.
- Peak return on assets (roa) was recorded in FY2016.
- Lowest return on assets (roa) in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 1.6% | +119.7% |
| FY2024 | -8.3% | -22.0% |
| FY2023 | -6.8% | -80.6% |
| FY2022 | -3.8% | +10.0% |
| FY2021 | -4.2% | -21.1% |
| FY2020 | -3.5% | -2.4% |
| FY2019 | -3.4% | -302.4% |
| FY2018 | -0.8% | -207.7% |
| FY2017 | 0.8% | -69.9% |
| FY2016 | 2.6% | +213.1% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026